September 25, 2022

Medical Trend

Medical News and Medical Resources

EU approves AstraZeneca’s COVID-19 vaccine as booster shot

EU approves AstraZeneca’s COVID-19 vaccine as booster shot



 

EU approves AstraZeneca’s COVID-19 vaccine as booster shot.

 

On May 23, British/Swedish multinational pharmaceutical company AstraZeneca said  that its COVID-19 vaccine Vaxzevria has been approved by the European Medicines Agency (EMA) as a booster vaccine for adults.

 

Last Thursday, AstraZeneca’s COVID-19 vaccine booster (clinical trial data) received a positive assessment from the European Committee for Medicinal Products for Human Use (CHMP).

 

EU approves AstraZeneca's COVID-19 vaccine as booster shot

 

AstraZeneca said in a statement on Monday that the company’s COVID-19 vaccine can be used as a booster shot for the first two doses of the Vaxzevria COVID-19 vaccine, as well as other messenger ribonucleic acid (mRNA) produced by companies such as Pfizer/BioNTech or Moderna. A booster shot of the COVID-19 vaccine.

 

The European Medicines Agency concluded that there was “substantial evidence” of an enhanced immune response following the administration of the Vaxzevria vaccine co-developed with the Oxford conference as a third booster dose, the statement said.

 

Despite a 40% drop in sales in Europe, where the outbreak is under control following the vaccination, AstraZeneca announced last month that sales of Vaxzevria quadrupled to US$1.15 billion in the first quarter. .
But AstraZeneca also warned in April that COVID-19 revenue, including Vaxzevria, would decline this year as the health crisis subsides.

 

 


Information about Vaxzevria

Vaxzevria is a vaccine for preventing coronavirus disease 2019 (COVID-19) in people aged 18 years and older. COVID-19 is caused by SARS-CoV-2 virus.

Vaxzevria is made up of another virus (of the adenovirus family) that has been modified to contain the gene for making a protein from SARS-CoV-2.

Vaxzevria does not contain the virus itself and cannot cause COVID-19.

Detailed information about this vaccine is available in the product information, which includes the package leaflet.

 

 

 

 

 

(source:internet, reference only)


Disclaimer of medicaltrend.org